420
Participants
Start Date
September 5, 2022
Primary Completion Date
December 30, 2025
Study Completion Date
March 30, 2026
Ambrisentan
"Titration:~Monotherapy using ambrisentan will be initialized at a beginning dose of 5 mg (once daily). Drug intake is scheduled at the morning. After 4 weeks monitoring, the dose of ambrisentan will be uptitrated to 10 mg once daily. Otherwise, if intolerability is indicated, a dose of 5 mg (once daily) will be maintained through the study duration.~Maximum dose allowed: not to exceed 10 mg/day.~Administration:~Ambrisentan will be administered orally with or without food intake."
Placebo
"Placebo tablet (one to two tablets corresponding to one to two verum tablets).~Administration:~Placebo will be administrated orally with or without food intake in the morning."
RECRUITING
Nanjing First Hospital, Nanjing
Tianjin Medical University General Hospital
OTHER
Nanjing First Hospital, Nanjing Medical University
OTHER